期刊文献+

多西紫杉醇联合表阿霉素辅助治疗乳腺癌28例 被引量:1

暂未订购
导出
摘要 目的观察多西紫杉醇联合表阿霉素辅助治疗乳腺癌的疗效与不良反应。方法临床确诊的28例乳腺癌患者第1天均给予表阿霉素快速静脉滴注,100 mg.(m2)-1;第2天给予多西紫杉醇缓慢静脉滴注,75 mg.(m2)-1;每3周为1个周期,常规治疗4个周期,有严重不良反应者减量或对症处理。结果肿瘤完全缓解3例(10.7%),部分缓解22例(78.6%),稳定3例(10.7%)。主要不良反应为骨髓抑制。结论多西紫杉醇联合表阿霉素辅助化疗方案治疗乳腺癌疗效确切,安全性较高,是治疗乳腺癌可行的方法。
出处 《医药导报》 CAS 2006年第8期797-798,共2页 Herald of Medicine
  • 相关文献

参考文献3

  • 1Amat S, Bougnoux P, Penanh L F,et al. Neoadjuvant docetaxel for operable breast cancer induces a high pathological response and breast-conservation rate [ J ]. Br J Cancer,2003,88 ( 9 ) : 1339 - 1345.
  • 2Cooper B, Silverman P, Overmoyer R, et al. Dose-dense doxomhin and docetaxel for patients with advanced operable and inoperable breast cancer[ J ]. Pruc Am Soc Clin Oncol,2003,22 ( 86 ) :342.
  • 3Hutcheon A W,Heys S D,Sarkar T K,et al. Aberdeen Breast Group.Neoadjuvant docetaxel in locally advanced breast caner [ J ]. Breast Cancer Nes Treat,2003,79 ( Suppl 1 ) : 519 - 524.

同被引文献6

  • 1宋向阳,李武平,孙惠英,代艳然.抗肿瘤药物性静脉炎的防护研究进展[J].护理研究(上旬版),2006,20(6):1417-1419. 被引量:32
  • 2Shimizu C,Ando M,Kouno T,et al.Current trends and controversies over pre-operative chemotherapy for women with operable breast cancer[J] .Jpn J Clin Oncol,2007,37(1):1-8.
  • 3Kaufmann M,von Minckwitz G,Bear HD,et al.Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer:new perspectives 2006[J].Ann Oncol,2007,18(12):1927-1934.
  • 4Ray-Coquard I,Bachelot T,Guastalla J.P.Epirubicin and paclitaxel (EPI-TAX regimen) for advanced ovarian cancer after failure of platinum-containing regimens[J].Gynecologic Oncology,2003,88:351-357.
  • 5Hosokawa T,Sami M,Kato Y,et al.Alteration in the Temperature-Dependent Content Release Property of Thermosensitive Liposomes in Plasma[J] .Chem Pharm Bull,2003,51(11):1227-1232.
  • 6吴燕,吴诚,康艳敏,梅兴国.表阿霉素脂质体的制备与质量评价[J].军事医学科学院院刊,2008,32(2):165-167. 被引量:5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部